454 related articles for article (PubMed ID: 27917196)
41. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
[TBL] [Abstract][Full Text] [Related]
42. HIV coinfections with tuberculosis among HIV-1 infected individuals in old cross river state, Nigeria.
Okonko IO; Ejike IU; Innocent-Adiele C; Cookey TI
J Immunoassay Immunochem; 2020 May; 41(3):245-256. PubMed ID: 31957554
[TBL] [Abstract][Full Text] [Related]
43. Effect of HIV infection on TB treatment outcomes and time to mortality in two urban hospitals in Ghana-a retrospective cohort study.
Ogyiri L; Lartey M; Ojewale O; Adjei AA; Kwara A; Adanu RM; Torpey K
Pan Afr Med J; 2019; 32():206. PubMed ID: 31312318
[TBL] [Abstract][Full Text] [Related]
44. Treatment outcome of TB/HIV positive and negative smear positive pulmonary tuberculosis patients treated using daily self-administered therapy in a Cameroonian district hospital.
Sume GE; Hoshen M; Bita G; Kabore S; Nzima VN
East Afr Med J; 2009 Oct; 86(10):469-75. PubMed ID: 21650070
[TBL] [Abstract][Full Text] [Related]
45. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
Azeez A; Mutambayi R; Odeyemi A; Ndege J
Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
[TBL] [Abstract][Full Text] [Related]
46. Home-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban Tanzania.
Mhimbira F; Hella J; Maroa T; Kisandu S; Chiryamkubi M; Said K; Mhalu G; Mkopi A; Mutayoba B; Reither K; Gagneux S; Fenner L
PLoS One; 2016; 11(8):e0161171. PubMed ID: 27513331
[TBL] [Abstract][Full Text] [Related]
47. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah TA; Ncayiyana JR; Nyasulu PS
Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
[TBL] [Abstract][Full Text] [Related]
48. HIV and tuberculosis co-infection in a highly HIV-infected population of rivers state, Nigeria.
Okonko IO; Anyanwu A; U Osadebe A; N Odu N
J Immunoassay Immunochem; 2018; 39(6):636-646. PubMed ID: 30296205
[TBL] [Abstract][Full Text] [Related]
49. High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study.
Adamu AL; Gadanya MA; Abubakar IS; Jibo AM; Bello MM; Gajida AU; Babashani MM; Abubakar I
BMC Infect Dis; 2017 Feb; 17(1):170. PubMed ID: 28231851
[TBL] [Abstract][Full Text] [Related]
50. Public-private mix for TB and TB-HIV care in Lagos, Nigeria.
Daniel OJ; Adedeji Adejumo O; Abdur-Razzaq HA; Ngozi Adejumo E; Salako AA
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1195-8. PubMed ID: 23928168
[TBL] [Abstract][Full Text] [Related]
51. Predictors of death during tuberculosis treatment in TB/HIV co-infected patients in Malaysia.
Ismail I; Bulgiba A
PLoS One; 2013; 8(8):e73250. PubMed ID: 23951346
[TBL] [Abstract][Full Text] [Related]
52. Tuberculosis in adolescents and young adults: epidemiology and treatment outcomes in the Western Cape.
Snow K; Hesseling AC; Naidoo P; Graham SM; Denholm J; du Preez K
Int J Tuberc Lung Dis; 2017 Jun; 21(6):651-657. PubMed ID: 28482959
[TBL] [Abstract][Full Text] [Related]
53. Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
Parchure R; Kulkarni V; Gangakhedkar R; Swaminathan S
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1348-1353. PubMed ID: 27725046
[TBL] [Abstract][Full Text] [Related]
54. Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6-9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan.
Wang JY; Sun HY; Wang JT; Hung CC; Yu MC; Lee CH; Lee LN
PLoS One; 2015; 10(12):e0144136. PubMed ID: 26633835
[TBL] [Abstract][Full Text] [Related]
55. Current characteristics of tuberculosis and human immunodeficiency virus co-infection in a cohort of hospitalized patients in Medellín, Colombia.
Ruiz L; Maya MA; Rueda ZV; López L; Vélez LA
Biomedica; 2018 Aug; 38(0):59-67. PubMed ID: 30184364
[TBL] [Abstract][Full Text] [Related]
56. [Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry].
Camara A; Sow MS; Touré A; Diallo OH; Kaba I; Bah B; Diallo TH; Diallo MS; Guilavogui T; Sow OY
Rev Epidemiol Sante Publique; 2017 Nov; 65(6):419-426. PubMed ID: 29066256
[TBL] [Abstract][Full Text] [Related]
57. Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes.
Monge S; Diez M; Pulido F; Iribarren JA; Campins AA; Arazo P; Montero M; Miro JM; Moreno S; Del Amo J;
Int J Tuberc Lung Dis; 2014 Jun; 18(6):700-8. PubMed ID: 24903942
[TBL] [Abstract][Full Text] [Related]
58. Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.
Nyasulu PS; Ngasama E; Tamuzi JL; Sigwadhi LN; Ozougwu LU; Nhandara RBC; Ayele BT; Umanah T; Ncayiyana J
PLoS One; 2022; 17(10):e0274549. PubMed ID: 36223365
[TBL] [Abstract][Full Text] [Related]
59. Profile of tuberculosis and its response to anti-TB drugs among tuberculosis patients treated under the TB control programme at Felege-Hiwot Referral Hospital, Ethiopia.
Zenebe Y; Adem Y; Mekonnen D; Derbie A; Bereded F; Bantie M; Tulu B; Hailu D; Biadglegne F
BMC Public Health; 2016 Aug; 16():688. PubMed ID: 27485507
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
